Molecular diagnostics for existing and emerging infections: Complementary tools for a new era of clinical microbiology

American Journal of Clinical Pathology

Volumn 112, Issue 1 SUPPL. 1, 1999, Pages

  Dumler, J Stephen ^a   Valsamakis, Alexandra ^a  

^a NONE

Author keywords

Bacterial toxins; Ehrlichia species; Enterovirus; Hepatitis C virus; Molecular diagnostics; PCR; Uncultured pathogens; Viral load

Indexed keywords

ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; BACTERIAL TOXIN; DNA; DNA POLYMERASE; RNA; STAPHYLOCOCCUS ENTEROTOXIN; VIRUS RNA;

ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; CLINICAL LABORATORY; EHRLICHIA; EHRLICHIOSIS; ENTEROVIRUS INFECTION; EPIDEMIC; HEALTH CARE COST; HEALTH CARE SYSTEM; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MENINGOENCEPHALITIS; MOLECULAR BIOLOGY; MYCOBACTERIUM; NUCLEIC ACID ANALYSIS; NUCLEIC ACID HYBRIDIZATION; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; TOXIC SHOCK SYNDROME; TOXOPLASMA GONDII; VIRULENCE; VIRUS INFECTION;

COMMUNICABLE DISEASES; GENETIC TECHNIQUES; GENETICS, MICROBIAL; HUMANS; MICROBIOLOGICAL TECHNIQUES;

EID: 0033506769     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. Morse SS. Factors in the emergence of infectious diseases. Emerg Infect Dis. 1995;1:7-15.
2. Lederberg J. Infectious diseases as an evolutionary paradigm. Emerg Infect Dis. 1997;4:417-423.
3. Morris JG, Potter M. Emergence of new pathogens as a function of changes in host susceptibility. Emerg Infect Dis. 1997;4:435-441.
4. Morse SS. Importance of molecular diagnostics in the identification and control of emerging infections. Emerg Infect Dis. 1996;1:201-206.
5. Tenover FC, Unger ER. Nucleic acid probes for detection and identification of infectious agents. In: Persing DH, Smith TF, Tenover FC, et al. Diagnostic Molecular Microbiology: Principles and Applications. Washington, DC: American Society for Microbiology; 1993:3-25.
6. Wolcott MJ. Advances in nucleic acid-based detection methods. Clin Microbiol Rev. 1992;5:370-386.
7. De Beenhouwer H, Lhiang Z, Jannes G, et al. Rapid detection of rifampicin resistance in sputum and biopsy specimens from tuberculosis patients by PCR and line probe assay. Tubercle Lung Dis. 1995;76:425-430.
8. Relman DA, Persing DH. Genotypic methods for microbial identification. In: Persing DH. PCR Protocols for Emerging Infectious Diseases. Washington, DC: American Society for Microbiology Press; 1996:3-32.
9. Wilson KH, Blitchington RB, Greene RC. Amplification of bacterial 16S ribosomal DNA with polymerase chain reaction. J Clin Microbiol 1990;28:1942-1946.
10. Relman DA, Loutit JS, Schmidt TM, et al. The agent of bacillary angiomatosis: an approach to the identification of uncultured pathogens. N Engl J Med. 1990;323:1573-1580.
11. Anderson BE, Dawson JE, Jones DC, et al. Ehrlichia chaffeensis: a new species associated with human ehrlichiosis. J Clin Microbiol. 1991;29:2838-2842.
12. Gao SJ, Moore PS. Molecular approaches to the identification of unculturable infectious agents. Emerg Infect Dis. 1996;2:159-167.
13. Chen SM, Dumler JS, Bakken JS, et al. Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease. J Clin Microbiol. 1994;32:589-595.
14. Relman DA, Schmidt TM, MacDermott RP, et al. Identification of the uncultured bacillus of Whipple's disease. N Engl J Med. 1992;327:293-301.
15. Wilson KH, Blitchington R, Frothingham R, et al. Phylogeny of the Whipple's-disease-associated bacterium. Lancet. 1991;338:474-475.
16. Wilson KH. Molecular biology as a tool for taxonomy. Clin Infect Dis. 1995;202:S117-S121.
17. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science. 1994;266:1865-1869.
18. Johnson WM, Tyler SD, Ewan EP, et al. Detection of genes for enterotoxins, exfoliative toxins, and toxic shock syndrome toxin 1 in Staphylococcus aureus by the polymerase chain reaction. J Clin Microbiol. 1991;29:426-430.
19. Hauser AR, Stevens DL, Kaplan EL, et al. Molecular analysis of pyrogenic exotoxins from Streptococcus pyogenes isolates associated with toxic shock-like syndrome. J Clin Microbiol. 1991;29:1562-1567.
20. Clementi M, Menzo S, Bagnarelli P, et al. Clinical use of quantitative molecular methods in studying human immunodeficiency virus type 1 infection. Clin Microbiol Rev. 1996;9:135-147.
21. Centers for Disease Control and Prevention. Summary of notifiable diseases: United States 1994. MMWR. 1995;43:3.
22. DeAngelis C, Joffe A, Wilson M, et al. Iatrogenic risk and financial costs of hospitalizing febrile infants. Am J Dis Child. 1983;137:1146-1149.
23. Ogborn CJ, Soulen JL, DeAngelis C. Hospitalization vs. outpatient treatment of young febrile infants: 10-year comparison. Arch Pediatr Adolesc Med. 1995;149:94-97.
24. Berlin LE, Rorabaugh ML, Heldrich F, et al. Aseptic meningitis in infants <2 years of age: diagnosis and etiology. J Infect Dis. 1993;168:888-892.
25. Rice SK, Heinl RE, Thomton LL, et al. Clinical characteristics, management strategies, and cost implications of a statewide outbreak of enterovirus meningitis. Clin Infect Dis. 1995;20:931-937.
26. Rothbart HA, Romero JR. Laboratory diagnosis of enteroviral infections. In: Rothbart HA, ed. Human Enterovirus Infections. Washington, DC: American Society for Microbiology Press; 1995:401-418.
27. Chapman NM, Tracy S, Gauntt CJ, et al. Molecular detection and identification of enteroviruses using enzymatic amplification and nucleic acid hybridization. J Clin Microbiol. 1990;28:843-850.
28. Sawyer MH, Holland D, Aintablian N, et al. Diagnosis of enteroviral central nervous system infection by polymerase chain reaction during a large community outbreak. Pediatr Infect Dis. 1994;13:177-182.
29. van der Avoort HG, Hull BP, Hovi T, et al. Comparative study of five methods for intratypic differentiation of polioviruses. J Clin Microbiol. 1995;33:2562-2566.
30. van Vliet KE, Glimaker M, Lebon P, et al. Multicenter evaluation of the Amplicor enterovirus PCR test with cerebrospinal fluid from patients with aseptic meningitis. The European Union Concerted Action on Viral Meningitis and Encephalitis. J Clin Microbiol. 1998;36:2652-2657.
31. Pozo F, Casas I, Tenorio A, et al. Evaluation of a commercially available reverse transcription-PCR assay for diagnosis of enteroviral infection in archival and prospectively collected cerebrospinal fluid specimens. J Clin Microbiol. 1998;36:1741-1745.
32. Romero J, Magelli M, Hinrichs S, et al. Reverse transcription-polymerase chain reaction (RT-PCR) diagnosis of enterovirus infections in febrile children results in reduced health care expenditures. In: Program and Abstracts of the 36th Annual Meeting of Infectious Diseases Society of America, Denver, Colorado, November 12-15, 1998. Abstract 668.
33. Parsonnet J. Nonmenstrual toxic shock syndrome: new insights into diagnosis, pathogenesis, and treatment. Curr Clin Top Infect Dis. 1996;16:1-20.
34. Strausbaugh LJ. Toxic shock syndrome: Are you recognizing its changing presentations? Postgrad Med. 1993;94:107-108.
35. Surh L, Read SE. Staphylococcal tracheitis and toxic shock syndrome in a young child. J Pediatr. 1984;105:585-587.
36. Solomon R, Truman T, Murray DL. Toxic shock syndrome as a complication of bacterial tracheitis. Pediatr Infect Dis. 1985;4:298-299.
37. Fast DJ, Schlievert PM, Nelson RD. Toxic shock syndrome-associated staphylococcal and streptococcal pyrogenic toxins are potent inducers of tumor necrosis factor production. Infect Immun. 1989;57:291-294.
38. Kappler J, Kotzin B, Herron L, et al. Vß-specific stimulation of human T cells by staphylococcal toxins. Science. 1989;244:811-813.
39. Stevens DL. Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment. Emerg Infect Dis. 1995;1:69-78.
40. Schmitz FJ, Steiert M, Hofmann B, et al. Development of a multiplex-PCR for direct detection of the genes for enterotoxin B and C, and toxic shock syndrome toxin-1 in Staphylococcus aureus isolates. J Med Microbiol. 1998;47:335-340.
41. Louie L, Simor AE, Louie M, et al. Diagnosis of group A streptococcal necrotizing fasciitis by using PCR to amplify the streptococcal pyrogenic exotoxin B gene. J Clin Microbio. 1998;36:1769-1771.
42. Ibrahim A, Liesack W, Griffiths MW, et al. Development of a highly specific assay for rapid identification of pathogenic strains of Yersinia enterocolitica based on PCR amplification of the Yersinia heat-stable enterotoxin gene (yst). J Clin Microbiol. 1997;35:1636-1638.
43. Paton AW, Paton JC. Detection and characterization of Shiga toxigenic Escherichia coli by using multiplex PCR assays for stx1, stx2, eaeA, enterohemorrhagic E. coli hlyA, rfbO111, and rfbO157. J Clin Microbiol. 1998;36:598-602.
44. Carroll KC, Leonard RB, Newcomb-Gayman PL, et al. Rapid detection of the staphylococcal mecA gene from BACTEC blood culture bottles by the polymerase chain reaction. Am J Clin Pathol. 1996;106:600-605.
45. Hoofnagle JH. Hepatitis C: the clinical spectrum of disease. Hepatology. 1997;26:15S-20S.
46. Gretch DR. Diagnostic tests for hepatitis C. Hepatology. 1997;26:43S-47S.
47. Krarup HB, Jacobsen SE, Varming K, et al. Performance of hepatitis C virus (HCV) antibody test systems in relation to HCV-RNA detection in the diagnosis of HCV infection. Dan Med Bull. 1998;45:89-91.
48. Berger A, Doerr HW, Prieser W, et al. Lack of correlation between different hepatitis C virus screening and confirmatory assays. J Virol Meth. 1996;59:141-146.
49. Donegan E, Wright TL, Roberts J, et al. Detection of hepatitis after liver transplantation: four serologic tests compared. Am J Clin Pathol. 1995;104:673-679.
50. Forns X, Bukh J. Methods for determining the hepatitis C virus genotype. Viral Hepatitis, 1998;4:1-19.
51. Davis GL, Lau JY. Factors predictive of a beneficial response to therapy of hepatitis C. Hepatology. 1997;26:122S-127S.
52. Brechet C. Hepatitis C virus 1b, cirrhosis, and hepatocellular carcinoma. Hepatology. 1997;25:772-774.
53. Feray C, Gigou M, Samuel D, et al. Influence of the genotypes of hepatitis C virus on the severity of recurrent disease after liver transplantation. Gastroenterology. 1995;108:1088-1096.
54. Gane EJ, Naoumov NV, Qian K-P, et al. A longitudinal analysis of hepatitis C replication following liver transplantation. Gastroenterology. 1996;110:167-177.
55. NIH management of hepatitis C. NIH Consensus Statement Online 1997 March 24-26;15:1-41.
56. Bakken JS, Dumler JS, Chen SM, et al. Human granulocytic ehrlichiosis in the upper midwest United States: a new species emerging? JAMA. 1994;272:212-218.
57. Kolbert CP, Bruinsma ES, Abdulkarim AS, et al. Characterization of an immunoreactive protein from the agent of human granulocytic ehrlichiosis. J Clin Microbiol. 1997;35:1172-1178.